Amnon Peled

机构：Hebrew University of Jerusalem, Hadassah Medical Center · ORCID：0009-0006-4973-2829

发表论文 293 篇 · 总被引 13905 次 · h-index 55

代表论文

• CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis (2023 · JCI Insight · 被引 44)
• Targeting CCL24 in Inflammatory and Fibrotic Diseases: Rationale and Results from Three CM-101 Phase 1 Studies (2024 · Drug Safety · 被引 15)
• The Role of CCL24 in Primary Sclerosing Cholangitis: Bridging Patient Serum Proteomics to Preclinical Data (2024 · Cells · 被引 15)
• SIL-204 siRNA encapsulated in extended release microparticles for the treatment of localized cancer that harbors a KRAS G12x or G13D mutation. (2025 · Journal of Clinical Oncology · 被引 5)
• DSP502 Combines Dual Inhibition of PD-L1 and PVR to Trigger Anticancer Immune Responses (2026 · Molecular Cancer Therapeutics · 被引 1)
• Identification of Dinaciclib and Ganetespib as anti-inflammatory drugs using a novel HTP screening assay that targets IFNγ-dependent PD-L1 (2025 · Frontiers in Immunology · 被引 1)